Cargando…

Evaluation of carotid artery dynamics & correlation with cardiac & hepatic iron in β-thalassaemia patients

BACKGROUND & OBJECTIVES: Early atherosclerosis and vascular complication have been described in thalassaemia patients. There is lack of data or guidelines regarding monitoring of vascular health in thalassaemia. This study was conducted to compare carotid artery structural and functional indices...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merchant, Rashid H., Chate, Someshwar, Ahmed, Javed, Ahmad, Noor, Karnik, Alka, Jankaria, Bhavin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928550/ https://www.ncbi.nlm.nih.gov/pubmed/27377500 http://dx.doi.org/10.4103/0971-5916.184302

Ejemplares similares

The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study
por: Berdoukas, Vasilios, et al.
Publicado: (2009)

Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major
por: Baksi, A. John, et al.
Publicado: (2014)

Hypochromic Anaemias Not Due to Iron Deficiency: Thalassaemia and Sideroblastic Anaemia
por: Weatherall, D. J.
Publicado: (1969)

α-thalassaemia
por: Harteveld, Cornelis L, et al.
Publicado: (2010)

Non-deletional alpha thalassaemia: a review
por: Kalle Kwaifa, Ibrahim, et al.
Publicado: (2020)

MRI evaluation of tissue iron burden in patients with β-thalassaemia major
por: Argyropoulou, Maria I., et al.
Publicado: (2007)

The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia
por: Kontoghiorghes, George J., et al.
Publicado: (2020)

Thalassaemia Intermedia: an Update
por: Taher, Ali T., et al.
Publicado: (2009)

Screening for beta thalassaemia
por: Petrou, Mary
Publicado: (2010)

Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study
por: Taher, Ali, et al.
Publicado: (2009)

Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE
por: Tran, Ngan Thi, et al.
Publicado: (2022)

The relationships between pancreatic T2* values and pancreatic iron loading with cardiac dysfunctions, hepatic and cardiac iron siderosis among Egyptian children and young adults with β-thalassaemia major and sickle cell disease: a cross-sectional study
por: Salama, Khaled, et al.
Publicado: (2021)

Thalassaemia and Aberrations of Growth and Puberty
por: Kyriakou, Andreas, et al.
Publicado: (2009)

THALASSAEMIA IS A TROPICAL DISEASE
por: Kotila, T.R.
Publicado: (2012)

Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry
por: Mohd Ibrahim, Hishamshah, et al.
Publicado: (2020)

Molecular and genetic characterization of hepatitis B virus among multitransfused thalassaemia patients in Islamabad, Pakistan
por: Farooq, Ahmad, et al.
Publicado: (2021)

Burden of ocular abnormalities in patients with beta thalassaemia: a cross-sectional study
por: Baig, Rashid, et al.
Publicado: (2023)

Efficiency and management factors: finding the balance in Thalassaemia care centres
por: Shafie, Asrul Akmal, et al.
Publicado: (2022)

Iron overload across the spectrum of non‐transfusion‐dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions
por: Porter, John B., et al.
Publicado: (2016)

Osteoporosis Syndrome in Thalassaemia Major: An Overview
por: Toumba, Meropi, et al.
Publicado: (2010)

Endocrine complications in patients with thalassaemia major
por: Meng, Zhe, et al.
Publicado: (2013)

Association of Beta-Thalassaemia and Hypogonadotropic Hypogonadism
por: Vidal, Angela, et al.
Publicado: (2022)

Factors affecting height in children and adolescents with transfusion-dependent Thalassaemia – results from a Thalassaemia center in Malaysia
por: Ting, Tzer Hwu, et al.
Publicado: (2013)

Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)
por: Vini, Dimitra, et al.
Publicado: (2011)

Retinal Nerve Fibre Layer Thinning in Patients with Thalassaemia, Iron Deficiency Anaemia, and Anaemia of Chronic Diseases
por: Datta, Suhana, et al.
Publicado: (2020)

Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia
por: Daar, Shahina, et al.
Publicado: (2009)

Aqueductal stenosis with optic atrophy in case of malignant osteopetrosis
por: Chate, Someshwar V., et al.
Publicado: (2011)

Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control
por: Suriapperuma, Tharindi, et al.
Publicado: (2018)

Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
por: Bentley, Anthony, et al.
Publicado: (2013)

Juvenile systemic lupus erythematosus: A diagnostic dilemma
por: Jaybhaye, Amol P., et al.
Publicado: (2011)

Alpha thalassaemia-mental retardation, X linked
por: Gibbons, Richard
Publicado: (2006)

Does α (+)-Thalassaemia Protect against Malaria?
por: Pasvol, Geoffrey
Publicado: (2006)

Preimplantation genetic diagnosis for α-thalassaemia in China
por: Xu, Yan-Wen, et al.
Publicado: (2009)

Epistasis and the sensitivity of phenotypic screens for beta thalassaemia
por: Penman, Bridget, et al.
Publicado: (2014)

Epistasis and the sensitivity of phenotypic screens for beta thalassaemia
por: Penman, Bridget S, et al.
Publicado: (2015)

Paraspinal mass in thalassaemia is often extramedullary haematopoiesis
por: Pandey, Gaurav, et al.
Publicado: (2015)

Status of Superoxide Dismutase in Transfusion Dependent Thalassaemia
por: Rujito, Lantip, et al.
Publicado: (2015)

Is β-Thalassaemia Minor Associated with Metabolic Disorder?
por: Kırım, Sinan, et al.
Publicado: (2014)

Molecular Characterization of α- and β-Thalassaemia among Malay Patients
por: Mohd Yatim, Nur Fatihah, et al.
Publicado: (2014)

Improved efficiency and patient safety through bespoke electronic thalassaemia care module
por: Naveed, Mohamed, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nm87iui6on2ebt3bvb1adf8rgn